Form 4 for RCEL AVITA Medical, Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-19 · accession 0001193125-26-064111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-19 | RCEL | O'Toole David D | CFO | P - Purchase | $4.15 | +3,000 | 140.1K | +2% | +$12.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-19 | P | A | 3,000 | $4.15 | 140,127 | D | — | — | (F1) Includes unvested RSUs. |